3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid
DB07031ExperimentalSmall molecule
3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid: Overview.
![Chemical structure of 3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid](/structures/DB07031/thumb.svg)
- Mechanism
- Curator reviewed
Pharmacologically active on Retinoic acid receptor gamma
- Formula / weight
- C23H26FNO4 · 399.4552 g/mol (avg)
- Code names
- BMS-270394 · BMS 961
Resolves to
Compound
Structure
InChIKey
AANFHDFOMFRLLR-LJQANCHMSA-NSMILESCC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@@H](O)C(=O)NC1=C(F)C=C(C=C1)C(O)=OTargets
What you can answer from here — as of August 26, 2024
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with 3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account